NEO

NEOPTERIN

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where NEO is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	2
Bond Count	30
Aromatic Bond Count	11

2D diagram of NEO

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	NEOPTERIN
Systematic Name (OpenEye OEToolkits)	2-amino-6-[(1R,2R)-1,2,3-trihydroxypropyl]-3H-pteridin-4-one
Formula	C₉ H₁₁ N₅ O₄
Molecular Weight	253.215
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C1c2nc(cnc2N=C(N1)N)C(O)C(O)CO
SMILES	CACTVS	3.341	NC1=Nc2ncc(nc2C(=O)N1)[CH](O)[CH](O)CO
SMILES	OpenEye OEToolkits	1.5.0	c1c(nc2c(n1)N=C(NC2=O)N)C(C(CO)O)O
Canonical SMILES	CACTVS	3.341	NC1=Nc2ncc(nc2C(=O)N1)[C@@H](O)[C@H](O)CO
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1c(nc2c(n1)N=C(NC2=O)N)[C@H]([C@@H](CO)O)O
InChI	InChI	1.03	InChI=1S/C9H11N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h1,4,6,15-17H,2H2,(H3,10,11,13,14,18)/t4-,6-/m1/s1
InChIKey	InChI	1.03	BMQYVXCPAOLZOK-INEUFUBQSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB02385
Name	D-threo-neopterin
Groups	experimental
Description	A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.
Synonyms	Neopterin D-threo-form D-threo-monapterin Monapterin D-threo-neopterin D-monapterin
Categories	Coenzymes Enzymes and Coenzymes Heterocyclic Compounds, Fused-Ring Pteridines Pterins
CAS number	10162-32-0

Related Resource References

Resource Name	Reference
PubChem	444632, 135460965, 5289005

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.